Similar articles for PMID: 24945109

Year	Number of Results
1949	1
1950	3
1951	4
1952	3
1955	5
1956	1
1957	1
1962	1
1963	1
1968	1
1997	1
2000	2
2001	6
2002	2
2003	5
2004	2
2005	6
2006	4
2007	6
2008	4
2009	1
2010	3
2012	1
2013	6
2014	5
2015	1
2017	2
2018	1
2019	1
2020	1
2021	1
2022	2
2023	1
2024	0

1

Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer.

Coss CC, Jones A, Dalton JT. Coss CC, et al. Steroids. 2014 Nov;90:94-100. doi: 10.1016/j.steroids.2014.06.010. Epub 2014 Jun 16. Steroids. 2014. PMID: 24945109 Review.

2

Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.

Baumann CK, Castiglione-Gertsch M. Baumann CK, et al. Minerva Ginecol. 2009 Dec;61(6):517-39. Minerva Ginecol. 2009. PMID: 19942839 Review.

3

Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature.

Saji S, Kuroi K. Saji S, et al. Breast Cancer. 2008;15(4):262-9. doi: 10.1007/s12282-008-0063-y. Epub 2008 Jul 25. Breast Cancer. 2008. PMID: 18654829 Review.

4

Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.

Johnston SR. Johnston SR. Clin Cancer Res. 2001 Dec;7(12 Suppl):4376s-4387s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916228 Review.

5

Novel androgen therapies including selective androgen receptor modulators.

Kang J, Chen R, Tharakan T, Minhas S. Kang J, et al. Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101686. doi: 10.1016/j.beem.2022.101686. Epub 2022 Jul 30. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35981955 Review.

6

Vascular effects of aromatase inhibitors: data from clinical trials.

Howell A, Cuzick J. Howell A, et al. J Steroid Biochem Mol Biol. 2005 May;95(1-5):143-9. doi: 10.1016/j.jsbmb.2005.04.005. J Steroid Biochem Mol Biol. 2005. PMID: 15936188

7

Toremifene for breast cancer: a review of 20 years of data.

Vogel CL, Johnston MA, Capers C, Braccia D. Vogel CL, et al. Clin Breast Cancer. 2014 Feb;14(1):1-9. doi: 10.1016/j.clbc.2013.10.014. Epub 2013 Oct 31. Clin Breast Cancer. 2014. PMID: 24439786 Free article. Review.

8

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Ciruelos E, Pascual T, Arroyo Vozmediano ML, Blanco M, Manso L, Parrilla L, Muñoz C, Vega E, Calderón MJ, Sancho B, Cortes-Funes H. Ciruelos E, et al. Breast. 2014 Jun;23(3):201-8. doi: 10.1016/j.breast.2014.01.016. Epub 2014 Mar 1. Breast. 2014. PMID: 24589524 Review.

9

Selective estrogen receptor modulators.

Haskell SG. Haskell SG. South Med J. 2003 May;96(5):469-76. doi: 10.1097/01.SMJ.0000051146.93190.4A. South Med J. 2003. PMID: 12911186 Review.

10

Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.

Diamanti-Kandarakis E, Sykiotis GP, Papavassiliou AG. Diamanti-Kandarakis E, et al. Cancer. 2003 Jan 1;97(1):12-20. doi: 10.1002/cncr.11049. Cancer. 2003. PMID: 12491500 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year